By proceeding, you agree to our Terms of Use and Privacy Policy.
La Jolla Pharmaceutical Company a subsidiary of Innoviva Inc is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life threatening diseases La Jolla markets GIAPREZA angiotensin II injection and XERAVA eravacycline for injection For more information please visit www ljpc com
07-08 September 2023
Since 2015, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet, brainstorm ideas and formulate initiatives that can effectively tackle antimicrobial resistance.
Event Ended
USA
Paid
Philadelphia